Main results of the EU Health Council on 14 June 2022

• European Health Data Space (European Commission)

Review of the EU global health strategy

EU health ministers exchanged on the EU global health strategy. In light of recent events – including the COVID-19 pandemic and the health and humanitarian crisis caused by the war in Ukraine – an update of the current strategy – dating back to 2010 – appears necessary.

On 19 May 2022, the Commission announced the launch of a process to develop a new EU global health strategy.

Ministers welcomed this decision to launch the review process. They stressed the importance of this strategy in redefining the EU’s global health priorities, such as strengthening health systems, preparing for and responding to health crises and promoting the One Health approach. Ministers also called for this strategy to strengthen the EU’s influence on health on the international scene and the coordination between relevant EU actors.

• Towards a new EU Global Health Strategy (European Commission)

The upcoming challenges of the EU’s COVID-19 vaccination strategy

During an informal exchange, ministers discussed the upcoming challenges of the EU’s COVID-19 vaccination strategy, both in terms of vaccine acquisition at European level and also in terms of international solidarity.

Other business

The French Presidency informed delegations about the state of play of the negotiations between the Council and the European Parliament with a view to reaching an agreement on a draft regulation on serious cross-border threats to health.

The European Commission has provided information on the implementation of the medical devices and health technology assessment regulations.

The Commission also briefed ministers on emerging health threats (cases of severe hepatitis in children and monkey pox), as well as on the health and humanitarian situation in Ukraine (in particular medical evacuations and health support for Ukraine).

The delegations of Belgium, the Netherlands, Luxembourg, Austria and Ireland discussed the market entry in Europe for drugs, including gaps in evidence and potential solutions.

The Bulgarian, Croatian, Estonian, Hungarian, Latvian, Lithuanian, Polish, Romanian, Slovak and Slovenian delegations informed the Council about their joint letter to the European Commission on the provisions of the COVID-19 vaccine purchase contracts.

Finally, the incoming Czech Presidency provided information on its work programme.

• European Health Union: protecting Europeans against cross-border health threats (background information)
• Health technology assessment (background information)